Schrödinger vs Veracyte
Veracyte reported revenue of $517 million in fiscal 2025, 2.0 times Schrödinger's $256 million in fiscal 2025. Schrödinger's revenue grew 23.3% in its latest year, and Veracyte's grew 16.0%. Schrödinger had an operating margin of -65.2%, against 11.2% at Veracyte. Free cash flow was $12 million at Schrödinger and $127 million at Veracyte.
Side by side
| Schrödinger | Veracyte | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $256M | $517M |
| Revenue growth | 23.3% | 16.0% |
| Revenue growth a year, last 5 years | 18.8% | 34.5% |
| Gross margin | 55.7% | 70.1% |
| Operating margin | −65.2% | 11.2% |
| Net margin | −40.4% | 12.8% |
| Free cash flow | $12M | $127M |
| Free cash flow margin | 4.9% | 24.5% |
| Return on capital | — | 6.1% |
| Net debt to EBITDA | — | −4.6x |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 1.1% | 3.1% |
| Last close | $29.82 | $24.16 |
| P/E at the last close | — | 15.7× |
| Insider trades, last 12 months | sold $2.3 million | sold $19.6 million |
| Piotroski F-score | — | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
SchrödingerVeracyte
Operating margin
Percent of revenue
SchrödingerVeracyte
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
SchrödingerVeracyte
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Schrödinger and Veracyte pages.